Baseline surface LILRB4 levels in two LILRB4-expressing monocytic AML cell lines (THP-1 and Mono-mac-6) were measured by flow cytometry with the same LILRB4-targeting antibody R193 (Fig. 1A). The gene discussed is LILRB4; the disease is acute myeloid leukemia.